Skip to main content
NVDA-2.45%AAPL+3.15%GOOGL+0.49%MSFT-0.06%AMZN-0.09%TSM-1.31%SPCX+0.86%AVGO-0.59%META-1.13%TSLA-0.39%SKHY-4.03%MU-4.35%BRK-B-0.24%LLY-0.02%JPM-0.67%WMT-0.13%AMD-3.08%V-0.21%XOM+0.53%ASMLa-1.66%JNJ-0.13%INTC-4.54%MA-0.58%0700.HK-1.94%1398.HK+0.79%ORCL-3.89%ABBV+0.98%BAC-0.53%CSCO-1.08%CVX-0.49%COST-0.18%KO+0.60%LRCX-4.97%CAT-1.40%AP2d-1.55%0005.HK-0.78%AMAT-2.55%UNH-0.99%HSBA.L-1.30%DELL-3.48%PG+0.50%MS-1.08%GE-0.68%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.18%HD-1.79%0939.HK+1.66%GS-1.13%NZDJPY-2.62%AUDJPY-1.82%CHFJPY-1.61%NZDCAD-1.47%EURNZD+1.45%NZDUSD-1.42%GBPNZD+1.39%GBPJPY-1.24%USDJPY-1.24%EURJPY-1.23%CADJPY-1.17%NZDCHF-1.05%USDZAR+0.98%USDNOK+0.90%USDSEK+0.86%AUDNZD+0.84%EURZAR+0.82%GBPZAR+0.74%EURNOK+0.74%EURSEK+0.70%AUDCAD-0.68%USDTHB+0.63%AUDDKK-0.63%EURAUD+0.60%AUDUSD-0.59%CHFNOK+0.57%GBPAUD+0.56%CHFSEK+0.53%AUDSGD-0.53%USDMXN+0.49%NZDSGD-0.43%CADCHF+0.42%USDPLN+0.42%GBPTRY+0.41%NOKJPY-0.40%USDCHF+0.38%EURCHF+0.38%GBPCHF+0.35%GBPHKD+0.32%GBPMXN-0.28%USDSGD+0.26%EURPLN+0.26%SGDJPY+0.24%NZDMXN-0.22%AUDCHF-0.21%EURHKD-0.17%USDDKK+0.16%USDILS+0.16%USDTRY+0.11%AUDNOK+0.11%EURSGD+0.10%USDCNH+0.10%GBPCAD-0.09%PLNJPY+0.08%CHFSGD-0.06%EURCAD-0.06%USDCAD-0.05%EURCZK-0.05%EURCNH-0.04%EURGBP+0.04%USDCOP-0.04%USDHKD+0.02%GBPSGD+0.01%GBPUSD-0.01%EURUSD+0.01%EURDKK0.00%XPTUSD-5.92%GAGUSD-5.01%XAGUSD-5.01%HG1-4.81%UKOIL+4.71%USOIL+4.53%XNGUSD+1.66%XAUUSD-1.56%GAUUSD-1.56%COTTON0.00%SUGAR0.00%W10.00%BTCUSD-1.33%ETHUSD-0.06%USDTUSD-0.04%XRPUSD-2.89%SOLUSD-1.66%TRXUSDT+0.24%ZECUSDT-8.33%DOGEUSD-2.54%XMRUSDT+0.39%LINKUSD-1.12%XLMUSD-1.19%BCHUSDT-9.71%LTCUSD-1.41%UNIUSD-0.88%TONUSD+24.88%HBARUSDT-2.25%SUIUSD-3.92%TAOUSDT-5.10%AAVEUSD-2.12%DOTUSDT-1.47%ICPUSDT-0.72%ONDOUSDT-3.01%WLDUSDT-2.67%ATOMUSDT-2.87%ARBUSDT+0.42%JUPUSDT-3.39%INJUSDT-2.26%STXUSDT-4.16%FETUSDT-2.62%TIAUSDT-0.34%PYTHUSDT-1.09%SEIUSDT-6.02%IMXUSDT-3.06%GRTUSDT-3.02%WIFUSDT-4.89%OPUSDT-3.00%POLUSDT-4.36%IOTAUSDT-3.35%AXSUSDT-2.14%FARTCOINUSDT-3.28%EOSUSDT-2.41%DYDXUSDT-1.84%ORDIUSDT-0.34%GALAUSDT-3.09%NOTUSDT-2.97%RONINUSDT-2.64%NVDA-2.45%AAPL+3.15%GOOGL+0.49%MSFT-0.06%AMZN-0.09%TSM-1.31%SPCX+0.86%AVGO-0.59%META-1.13%TSLA-0.39%SKHY-4.03%MU-4.35%BRK-B-0.24%LLY-0.02%JPM-0.67%WMT-0.13%AMD-3.08%V-0.21%XOM+0.53%ASMLa-1.66%JNJ-0.13%INTC-4.54%MA-0.58%0700.HK-1.94%1398.HK+0.79%ORCL-3.89%ABBV+0.98%BAC-0.53%CSCO-1.08%CVX-0.49%COST-0.18%KO+0.60%LRCX-4.97%CAT-1.40%AP2d-1.55%0005.HK-0.78%AMAT-2.55%UNH-0.99%HSBA.L-1.30%DELL-3.48%PG+0.50%MS-1.08%GE-0.68%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.18%HD-1.79%0939.HK+1.66%GS-1.13%NZDJPY-2.62%AUDJPY-1.82%CHFJPY-1.61%NZDCAD-1.47%EURNZD+1.45%NZDUSD-1.42%GBPNZD+1.39%GBPJPY-1.24%USDJPY-1.24%EURJPY-1.23%CADJPY-1.17%NZDCHF-1.05%USDZAR+0.98%USDNOK+0.90%USDSEK+0.86%AUDNZD+0.84%EURZAR+0.82%GBPZAR+0.74%EURNOK+0.74%EURSEK+0.70%AUDCAD-0.68%USDTHB+0.63%AUDDKK-0.63%EURAUD+0.60%AUDUSD-0.59%CHFNOK+0.57%GBPAUD+0.56%CHFSEK+0.53%AUDSGD-0.53%USDMXN+0.49%NZDSGD-0.43%CADCHF+0.42%USDPLN+0.42%GBPTRY+0.41%NOKJPY-0.40%USDCHF+0.38%EURCHF+0.38%GBPCHF+0.35%GBPHKD+0.32%GBPMXN-0.28%USDSGD+0.26%EURPLN+0.26%SGDJPY+0.24%NZDMXN-0.22%AUDCHF-0.21%EURHKD-0.17%USDDKK+0.16%USDILS+0.16%USDTRY+0.11%AUDNOK+0.11%EURSGD+0.10%USDCNH+0.10%GBPCAD-0.09%PLNJPY+0.08%CHFSGD-0.06%EURCAD-0.06%USDCAD-0.05%EURCZK-0.05%EURCNH-0.04%EURGBP+0.04%USDCOP-0.04%USDHKD+0.02%GBPSGD+0.01%GBPUSD-0.01%EURUSD+0.01%EURDKK0.00%XPTUSD-5.92%GAGUSD-5.01%XAGUSD-5.01%HG1-4.81%UKOIL+4.71%USOIL+4.53%XNGUSD+1.66%XAUUSD-1.56%GAUUSD-1.56%COTTON0.00%SUGAR0.00%W10.00%BTCUSD-1.33%ETHUSD-0.06%USDTUSD-0.04%XRPUSD-2.89%SOLUSD-1.66%TRXUSDT+0.24%ZECUSDT-8.33%DOGEUSD-2.54%XMRUSDT+0.39%LINKUSD-1.12%XLMUSD-1.19%BCHUSDT-9.71%LTCUSD-1.41%UNIUSD-0.88%TONUSD+24.88%HBARUSDT-2.25%SUIUSD-3.92%TAOUSDT-5.10%AAVEUSD-2.12%DOTUSDT-1.47%ICPUSDT-0.72%ONDOUSDT-3.01%WLDUSDT-2.67%ATOMUSDT-2.87%ARBUSDT+0.42%JUPUSDT-3.39%INJUSDT-2.26%STXUSDT-4.16%FETUSDT-2.62%TIAUSDT-0.34%PYTHUSDT-1.09%SEIUSDT-6.02%IMXUSDT-3.06%GRTUSDT-3.02%WIFUSDT-4.89%OPUSDT-3.00%POLUSDT-4.36%IOTAUSDT-3.35%AXSUSDT-2.14%FARTCOINUSDT-3.28%EOSUSDT-2.41%DYDXUSDT-1.84%ORDIUSDT-0.34%GALAUSDT-3.09%NOTUSDT-2.97%RONINUSDT-2.64%
LT

Larimar Therapeutics, Inc. (LRMR)

NASDAQ • Healthcare

$3.87
-$0.2 (-5.1%)
Market open

Last close at September 9, 2026 at 20:00 UTC

Open$4.03
Previous Close$3.87
Day Range$3.83 - $4.17
Avg. Volume (3M)909.3K
Market Cap$392.9M
52 Week Range
$2.72$6.42
Next EarningsIn 56 daysNov 5, 2026

Metrics Over Time

Fundamentals & Financials

Revenue (TTM)
$0
Net Income (TTM)
-$172.6M
EPS (TTM)
-$1.99
ROA (TTM)
-104.42%
Current Ratio
4.7

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-65.9%Q1 2026-$0.73
+41.5%Q2 2026-$0.31
+21.4%Q3 2026-$0.3
Next

Nov 5

in 56 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About Larimar Therapeutics, Inc.

Larimar Therapeutics, Inc. is a NASDAQ-listed healthcare company in biotechnology that operates as a clinical-stage drug developer focused on rare diseases. The company centers its work on CTI-1601, a therapy candidate for Friedreich's ataxia, and its current profile is that of an early-stage biotech rather than a commercial medicine business.

Name
Larimar Therapeutics, Inc.
CEO
Carole S. Ben-Maimon
Website
www.larimartx.com
Industry
Healthcare
Employees
71

Today's Snapshot

AI-generated

LRMR is trading 2.2% below yesterday's close, while its sector was flat.

Trading Volume

Below 10d avg (713.1K)

383.6K

vs S&P 500 Today

Underperforming Market

-1.61%

Updated: September 10, 2026 at 16:40 UTC

Technical Indicators

0 Buy2 Neutral6 Sell
LRMR is exhibiting clear distribution characteristics: the price around 3.78 sits beneath its short- and medium-term moving averages and below the 200-day averages, while the VWAP is essentially level with the current quote, suggesting intraday weakness. Momentum readings are negative—CCI is deeply negative and MACD is below zero—while RSI is neutral-to-soft, and on-balance volume points to net selling pressure. Volatility is moderate with ATR near $0.21, and ADX around 21 indicates only a modest directional strength to the downside. Technical takeaway: Strong Sell.
All signals
  • EMA (5 indicators)$3.92 - $3.98
    Sell
  • RSI (14)43.21
    Neutral
  • Stochastic %K (14, 3, 3)32.75
    Neutral
  • MACD Level (12, 26)-0.04
    Sell

Peers & Related Assets

ANNXAnnexon, Inc.
$4.37-6.4%
ALTAltimmune, Inc.
$3.35-0.3%
LXEOLexeo Therapeutics, Inc. Common Stock
$4.48-5.9%
KRROKorro Bio, Inc.
$12.93-4.3%
ANROAlto Neuroscience, Inc.
KYTXKyverna Therapeutics, Inc.
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.